Meta‐analysis: Histological severity of biopsy‐proven metabolic dysfunction‐associated steatotic liver disease in pediatric patients
Journal of Pediatric Gastroenterology and Nutrition · 2025
DOI: 10.1002/jpn3.70157 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Matheus Souza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Fatty Liver, Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
The burden of metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasing in children and adolescents. However, the severity of disease at diagnosis by liver biopsy remains uncertain and has not been systematically evaluated. We conducted a systematic review and meta‐analysis to determine the prevalence of metabolic dysfunction‐associated steatohepatitis (MASH), significant and advanced fibrosis in this population. PubMed and Embase databases were systematically searched (from inception to September 17, 2024) for studies reporting liver histology in pediatric patients (≤21 years) with biopsy‐proven MASLD. Meta‐analysis of proportions was performed using a generalized linear mixed model with Clopper‐Pearson intervals to obtain pooled prevalence estimates. Of 4761 records identified, we included 35 studies with 5898 pediatric patients with biopsy‐proven MASLD (33.4% girls; mean age 12.6 years). The pooled prevalences of MASH, significant fibrosis (defined as ≥F2) and advanced fibrosis (defined as ≥F3) based on histology were 59.95% ( n = 18 studies, 95% confidence interval [CI]: 46.89–71.73, I ² = 97%), 30.53% ( n = 26 studies, 95% CI: 22.32–40.20, I ² = 94%), and 11.77% ( n = 28 studies, 95% CI: 8.10–16.80, I ² = 89%), respectively. Subgroup analyses showed higher prevalence of advanced fibrosis in studies with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Medicine, Universidad de Buenos Aires, Buenos Aires, Argentina.
- Department of Medicine, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
ORCID-Profile: Matheus Souza, Samira Mohamad Khalil, Fabiana Dolovitsch de Oliveira
Förderung
- None
Zitieren
APA
Souza, M., Khalil, S. M., & de Oliveira, F. D. (2025). Meta‐analysis: Histological severity of biopsy‐proven metabolic dysfunction‐associated steatotic liver disease in pediatric patients. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70157
Vancouver
Souza M, Khalil SM, de Oliveira FD. Meta‐analysis: Histological severity of biopsy‐proven metabolic dysfunction‐associated steatotic liver disease in pediatric patients. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70157
BibTeX
@article{Souza2025,
author = {Souza, Matheus and Khalil, Samira Mohamad and de Oliveira, Fabiana Dolovitsch},
title = {Meta‐analysis: Histological severity of biopsy‐proven metabolic dysfunction‐associated steatotic liver disease in pediatric patients},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
doi = {10.1002/jpn3.70157}
}
EUVIMED